Aduro BioTech's Series A - II Round

Aduro BioTech raised a round of funding on November 13, 2009.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine platforms. The company is also advancing a n…

Articles about Aduro BioTech's Series A - II Round: